WHO Guideline on the Use of Safety-engineered Syringes for Intramuscular, Intradermal, and Subcutaneous Injections in Health-care Settings
WHO Guideline on the Use of Safety-engineered Syringes for Intramuscular, Intradermal, and Subcutaneous Injections in Health-care Settings

Author: World Health Organization

Publisher:

Published: 2015

Total Pages: 32

ISBN-13:

DOWNLOAD EBOOK

This guideline provides global, evidence-based recommendations on the use of safety-engineered injection devices to prevent the reuse of syringes and/or prevent needle-stick injuries in health-care workers. The ultimate aim is to make injection practices safer for patients and health-care workers and to prevent the injection-related transmission of deadly viruses, particularly HIV, Hepatitis C and Hepatitis B. The procedures covered are intramuscular (IM), intradermal (ID) and subcutaneous (SC) injections including the syringes needed for the reconstitution of medication or vaccines when required. Other procedures e.g. intravenous injections and infusions, blood collection for laboratory testing, and capillary blood sampling will be covered by another guideline to be issued separately by WHO. The policy recommendation aims to support Member States (MS) and development partners in making informed decisions on the appropriateness of introducing safety-engineered syringes for all injections in health-care settings.

WHO Best Practices for Injections and Related Procedures Toolkit
WHO Best Practices for Injections and Related Procedures Toolkit

Author:

Publisher:

Published: 2010

Total Pages: 55

ISBN-13: 9789241599252

DOWNLOAD EBOOK

The new WHO guidelines provide recommended steps for safe phlebotomy and reiterate accepted principles for drawing, collecting blood and transporting blood to laboratories/blood banks. The main areas covered by the toolkit are: 1. bloodborne pathogens transmitted through unsafe injection practices;2. relevant elements of standard precautions and associated barrier protection;3. best injection and related infection prevention and control practices;4. occupational risk factors and their management.

Manual of Infection Prevention and Control
Manual of Infection Prevention and Control

Author: Nizam Damani

Publisher: Oxford University Press

Published: 2019-02-14

Total Pages: 512

ISBN-13: 0192547941

DOWNLOAD EBOOK

In recent years, we have begun to recognise the rising threat of Multidrug Resistant Organisms (MDORs), and the profound impact that healthcare associated infections (HCAIs), such as MRSA, can have on both patient safety and quality of care. HCAIs prolong patients' hospital stays, and increase morbidity as well as mortality rates, yet diagnosing and treating these infections is a costly process that can place intense pressure on already limited healthcare resources. The updated and significantly expanded new edition of Manual of Infection Prevention and Control is a practical handbook that provides a comprehensive overview of HCAI control and prevention in all healthcare facilities. Clear diagrams and quick-access tables give step-by-step instructions to guide the reader through real-life prevention strategies such as hand wash, disinfection, and sterilisation. A truly current and global source, this book also includes information regarding infection outbreak management, and detailed sections on specific pathogens such as swine flu, C Difficile, ESBL, MRSA, E.coli 0157, XDR-TB, and Ebola. Manual of Infection Prevention and Control is a fully illustrated, evidence based guide for doctors, nurses, and public health physicians working to prevent the spreading of infectious diseases - most particularly HCAIs. It is also a valuable reference for environmental health officers, health educators, practice managers in GP surgeries, and health service managers.

Compendium of WHO and other UN guidance in health and environment, 2024 update
Compendium of WHO and other UN guidance in health and environment, 2024 update

Author: World Health Organization

Publisher: World Health Organization

Published: 2024-07-02

Total Pages: 250

ISBN-13: 9240095381

DOWNLOAD EBOOK

This is the 2024 update of the Compendium of WHO and other UN guidance on health and environment. The Compendium is a comprehensive collection of available WHO and other UN guidance for improving health by creating healthier environments. It provides an overview and easy access of more than 500 actions, and a framework for thinking about health and environment interventions. It covers a broad range of areas such as air pollution, water, sanitation and hygiene, climate change, chemicals, radiation, or food systems. Guidance is classified according to principal sectors involved, level of implementation (national, community, health care), the type of instrument (taxes, infrastructure etc.) and the category of evidence. The Compendium compiles existing guidance from hundreds of documents in a simple and systematized format. To ensure the most up-to-date information is provided to the end users, the Compendium is updated on a regular basis and incorporates the latest major WHO or other UN guidance on health and environment. The target audience includes any decision-makers with relevance to health and environment, and those assisting them (such as mayors, staff in ministries, UN country staff etc.). The Compendium has been prepared by WHO in cooperation with UN Environment, UNDP and UNICEF.

WHO guideline on school health services
WHO guideline on school health services

Author: World Health Organization

Publisher: World Health Organization

Published: 2021-06-22

Total Pages: 97

ISBN-13: 9240029397

DOWNLOAD EBOOK

WHO has long recognized the link between health and education and the potential for schools to play a central role in safeguarding student health and well-being. In 1995, WHO launched the Global School Health Initiative, which aimed to strengthen approaches to health promotion in schools. This WHO guideline on school health services will contribute to the creation of a common language around school health services, will promote evidence-based care through its menu of interventions, will strengthen school nursing and school health professions around the world, and ultimately will improve the health of children.

Canadian Immunization Guide
Canadian Immunization Guide

Author: Canada. Comité consultatif national de l'immunisation

Publisher:

Published: 2006

Total Pages: 392

ISBN-13: 9780660193922

DOWNLOAD EBOOK

The seventh edition of the Canadian Immunization Guide was developed by the National Advisory Committee on Immunization (NACI), with the support ofthe Immunization and Respiratory Infections Division, Public Health Agency of Canada, to provide updated information and recommendations on the use of vaccines in Canada. The Public Health Agency of Canada conducted a survey in 2004, which confi rmed that the Canadian Immunization Guide is a very useful and reliable resource of information on immunization.

Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection
Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection

Author: World Health Organization

Publisher: World Health Organization

Published: 2024-03-28

Total Pages: 272

ISBN-13: 9240090908

DOWNLOAD EBOOK

Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease. The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expanded eligibility for antiviral prophylaxis for pregnant women to prevent mother-to-child transmission of HBV; improving HBV diagnostics through use of point-of-care HBV DNA viral load and reflex approaches to HBV DNA testing; who to test and how to test for HDV infection; and approaches to promote delivery of high-quality HBV services, including strategies to promote adherence to long-term antiviral therapy and retention in care. The 2024 guidelines include 11 updated chapters with new recommendations and also update existing chapters without new recommendations, such as those on treatment monitoring and surveillance for liver cancer.

Guidelines for the Prevention Care and Treatment of Persons with Chronic Hepatitis B Infection
Guidelines for the Prevention Care and Treatment of Persons with Chronic Hepatitis B Infection

Author: World Health Organization

Publisher: World Health Organization

Published: 2015-08-05

Total Pages: 166

ISBN-13: 924154905X

DOWNLOAD EBOOK

These are the first World Health Organization (WHO) guidelines for the prevention care and treatment of persons living with CHB infection and complement similar recent published guidance by WHO on the prevention care and treatment of infection due to the hepatitis C virus (HCV). In contrast to several recent international guidelines on the management of CHB infection from the United States Europe Asia-Pacific and the United Kingdom (UK) the primary audience for these WHO guidelines is country programme managers in all settings but particularly in LMICs to help plan the development and scale up of hepatitis B prevention care and treatment. These guidelines are also intended for health-care providers who care for persons with CHB in these settings. The recommendations are structured along the continuum of care for persons with CHBa from initial assessment of stage of disease and eligibility for treatment to initiation of first-line antiviral therapy and monitoring for disease progression toxicity and HCC and switch to second-line drugs in persons with treatment failure. They are intended for use across age groups and adult populations. The recommendations in these guidelines promote the use of simple non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of nucleos(t)ide analogues with a high barrier to drug resistance (tenofovir and entecavir and entecavir in children aged 2–11 years) for first- and second-line treatment. These guidelines also recommend lifelong treatment in those with cirrhosis; and regular monitoring for disease progression toxicity of drugs and early detection of HCC. An additional chapter highlights management considerations for specific populations including those coinfected with HIV HCV and hepatitis D virus (HDV); children and adolescents; and pregnant women.

Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection Updated Version April 2016
Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection Updated Version April 2016

Author: World Health Organization

Publisher: World Health Organization

Published: 2016-04-30

Total Pages: 140

ISBN-13: 9241549610

DOWNLOAD EBOOK

The field of HCV therapeutics continues to evolve rapidly and since the World Health Organization (WHO) issued its first Guidelines for the screening care and treatment of persons with hepatitis C infection in 2014 several new medicines have been approved by at least one stringent regulatory authority. These medicines called direct-acting antivirals (DAAs) are transforming the treatment of HCV enabling regimens that can be administered orally are of shorter duration (as short as eight weeks) result in cure rates higher than 90% and are associated with fewer serious adverse events than the previous interfere on containing regimens. WHO is updating its hepatitis C treatment guidelines to provide recommendations for the use of these new medicines. The objectives of these WHO guidelines are to provide updated evidence-based recommendations for the treatment of persons with hepatitis C infection using where possible all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient?s HCV genotype and clinical history and assess the appropriateness of continued use of certain medicines. This document also includes existing recommendations on screening for HCV infection and care of persons infected with HCV that were first issued in 2014. The key audience for these guidelines are policy-makers in low- and middle-income countries who formulate country-specific treatment guidelines and who plan infectious disease treatment programmes and services in addition to those people responsible for delivering treatment. The guidelines are appropriate for all countries including high-income countries.